142 related articles for article (PubMed ID: 24405602)
1. [Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis].
Wang X; Zhang Z; Liu Y; Wang L; Yuan H; Xie P; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):75-8. PubMed ID: 24405602
[TBL] [Abstract][Full Text] [Related]
2. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
3. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
[TBL] [Abstract][Full Text] [Related]
4. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
[TBL] [Abstract][Full Text] [Related]
8. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
[TBL] [Abstract][Full Text] [Related]
9. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
[TBL] [Abstract][Full Text] [Related]
10. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
[TBL] [Abstract][Full Text] [Related]
11. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
[TBL] [Abstract][Full Text] [Related]
12. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between Expression of CD200 and Regulatory T Cells in Multiple Myeloma and Its Significance in Prognostic Stratification].
Zhu MX; Wan WL; Li HS; Wang YF; Wang J; Ling HS; Yan XX; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1427-1432. PubMed ID: 27784369
[TBL] [Abstract][Full Text] [Related]
14. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
Jalal SD
PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
[TBL] [Abstract][Full Text] [Related]
15. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
16. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
17. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
18. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
[TBL] [Abstract][Full Text] [Related]
20. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
